Robert Gerwien

1.1k total citations
39 papers, 815 citations indexed

About

Robert Gerwien is a scholar working on Molecular Biology, Epidemiology and Experimental and Cognitive Psychology. According to data from OpenAlex, Robert Gerwien has authored 39 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in Robert Gerwien's work include Digital Mental Health Interventions (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Sleep and related disorders (5 papers). Robert Gerwien is often cited by papers focused on Digital Mental Health Interventions (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Sleep and related disorders (5 papers). Robert Gerwien collaborates with scholars based in United States, Denmark and Canada. Robert Gerwien's co-authors include David J. Stone, Erik C. Gunther, Patrícia Meira Bento, Melvyn P. Heyes, Janice A. Kolberg, Mickey S. Urdea, Oluf Pedersen, Torben Jørgensen, Michael W. Rowe and Torben Hansen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert Gerwien

39 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Gerwien United States	15	328	112	112	89	76	39	815
Mingqing Xu China	28	765 2.3×	212 1.9×	77 0.7×	132 1.5×	16 0.2×	50	1.9k
Bingbing Fan China	13	216 0.7×	44 0.4×	60 0.5×	122 1.4×	11 0.1×	46	748
Simona Vuletic United States	17	290 0.9×	67 0.6×	120 1.1×	88 1.0×	22 0.3×	24	792
Yoko Hara Japan	15	201 0.6×	111 1.0×	93 0.8×	64 0.7×	5 0.1×	30	763
Vincent P. Diego United States	17	215 0.7×	103 0.9×	98 0.9×	12 0.1×	24 0.3×	50	792
Toomas Haller Estonia	9	280 0.9×	93 0.8×	48 0.4×	40 0.4×	10 0.1×	21	712
Chloe Thomas United Kingdom	16	447 1.4×	80 0.7×	53 0.5×	125 1.4×	33 0.4×	52	926
Danjie Jiang China	17	419 1.3×	91 0.8×	49 0.4×	61 0.7×	5 0.1×	47	761
H Lippman United States	13	240 0.7×	181 1.6×	37 0.3×	44 0.5×	14 0.2×	36	786
Melissa Smart United Kingdom	19	610 1.9×	80 0.7×	178 1.6×	28 0.3×	13 0.2×	24	1.3k

Countries citing papers authored by Robert Gerwien

Since Specialization

Citations

This map shows the geographic impact of Robert Gerwien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Gerwien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Gerwien more than expected).

Fields of papers citing papers by Robert Gerwien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Gerwien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Gerwien. The network helps show where Robert Gerwien may publish in the future.

Co-authorship network of co-authors of Robert Gerwien

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Gerwien. A scholar is included among the top collaborators of Robert Gerwien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Gerwien. Robert Gerwien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thorndike, Frances P., Charles M. Morin, Joseph Ojile, et al.. (2024). Effect of a prescription digital therapeutic for chronic insomnia on post-treatment insomnia severity, depression, and anxiety symptoms: results from the real-world DREAM study. Frontiers in Psychiatry. 15. 1450615–1450615. 3 indexed citations

Morin, Charles, et al.. (2023). Digital CBT-I Treatment Improves Sleep and Reduces Anxiety and Depression Symptoms in Adults With Chronic Insomnia: Interim Analysis of DREAM Study. CNS Spectrums. 28(2). 227–228. 2 indexed citations

Luderer, Hilary F., Nicole M. Enman, Robert Gerwien, et al.. (2022). A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study. JMIR Research Protocols. 12. e43122–e43122. 3 indexed citations

Ritterband, Lee M., Frances P. Thorndike, Charles M. Morin, et al.. (2022). Real-world evidence from users of a behavioral digital therapeutic for chronic insomnia. Behaviour Research and Therapy. 153. 104084–104084. 25 indexed citations

Luderer, Hilary F., Lisa M. Chiodo, Christina Brezing, et al.. (2021). Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial. JMIR Research Protocols. 11(1). e32759–e32759. 3 indexed citations

Ghaemi, S. Nassir, et al.. (2021). A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial. JMIR Formative Research. 6(3). e29154–e29154. 27 indexed citations

Luderer, Hilary F., Aimee Campbell, Edward V. Nunes, et al.. (2021). Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes. Journal of Substance Abuse Treatment. 132. 108585–108585. 12 indexed citations

Peacock, W. Frank, Timothy Van Meter, Robert Gerwien, et al.. (2017). Derivation of a Three Biomarker Panel to Improve Diagnosis in Patients with Mild Traumatic Brain Injury. Frontiers in Neurology. 8. 641–641. 33 indexed citations

Rowe, M.T., et al.. (2017). An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors. PLoS neglected tropical diseases. 11(9). e0005882–e0005882. 10 indexed citations

10.

Skali, Hicham, Robert Gerwien, Timothy E. Meyer, et al.. (2016). Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT. Journal of Cardiovascular Translational Research. 9(5-6). 421–428. 30 indexed citations

11.

Reinhart, Veronica, Tri‐Hung Nguyen, Robert Gerwien, et al.. (2014). Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro. Neuroscience. 278. 62–69. 9 indexed citations

12.

McKenna, Michael P., Valeriya Lyssenko, Michael W. Rowe, et al.. (2009). The diabetes risk score outperforms fasting plasma glucose and glucose tolerance tests: combined results from the Inter99 and Botnia Studies. Lund University Publications (Lund University). 1 indexed citations

13.

Hawthorne, Thomas, Loïc Giot, Lauren E. Blake, et al.. (2008). A Phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D. International Journal of Clinical Pharmacology and Therapeutics. 46(5). 236–244. 25 indexed citations

14.

Schuster, Michael W., Tsiporah B. Shore, John G. Harpel, et al.. (2007). Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant. Supportive Care in Cancer. 16(5). 477–483. 14 indexed citations

15.

Pollack, Vincent A., Enrique Álvarez, Michael Torgov, et al.. (2007). Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB. Cancer Chemotherapy and Pharmacology. 60(3). 423–435. 58 indexed citations

16.

Gunther, Erik C., David J. Stone, Jonathan M. Rothberg, & Robert Gerwien. (2005). A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action. The Pharmacogenomics Journal. 5(2). 126–134. 14 indexed citations

17.

MacLachlan, Timothy K., Bhagavathi A. Narayanan, Valerie L. Gerlach, et al.. (2005). Human fibroblast growth factor 20 (FGF-20; CG53135-05): A novel cytoprotectant with radioprotective potential. International Journal of Radiation Biology. 81(8). 567–579. 27 indexed citations

18.

Álvarez, Enrique, Valerie L. Gerlach, Robert Gerwien, et al.. (2005). Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05) Reduces the Severity and Duration of Oral Mucositis. PubMed. 2(2). 122–127. 8 indexed citations

19.

Gunther, Erik C., David J. Stone, Robert Gerwien, Patrícia Meira Bento, & Melvyn P. Heyes. (2003). Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proceedings of the National Academy of Sciences. 100(16). 9608–9613. 148 indexed citations

20.

Gerwien, Robert & Henry B. John‐Alder. (1992). Growth and behavior of thyroid-deficient lizards (Sceloporus undulatus). General and Comparative Endocrinology. 87(2). 312–324. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact